The first Dundee derby of the 2025-26 Scottish Premiership season will take place on Saturday, 30 August. Jim Goodwin's side make the short walk up the street to Dens Park for a 15:00 BST kick-off.

Your one-stop shop for all the ins and outs in the Scottish Premiership during the 2025 summer transfer window.

Stockport were the most accurate crossers (26.5%) with Wycombe close behind (23.2%). Both teams finished in the play-offs but missed out on the Wembley final. Wrexham, as mentioned, Mansfield and ...

Dundee United sign Moldova defender Iurie Iovu from Istra 1961 and Australian forward Zac Sapsford from Western Sydney Wanderers.

Manager Jim Goodwin confirmed Dundee United are "not finished" in the transfer market after he praised the "great business" the club have done already. United kicked-off their pre-season with a 3-0 ...

Dundee United have targeted 25-year-old Ukrainian goalkeeper Yevhen Kucherenko, currently with LNZ Cherkasy in his homeland's top flight, and are in advanced talks with a central midfielder and ...

Hibs transfer latest: Ex forward exits Dundee United, SWPL contract extension, club get mention in done deal By Ben Banks Sports editor & journalist Comment Published 4th Jun 2025, 09:21 BST ...

Dundee United have finalised their pre-season schedule, which includes a trip to the Netherlands. The Tangerines had already confirmed their first two pre-season games, the first, at Glebe Park ...

Dundee United return to European football after a two-year absence in Wednesday's Conference League second round qualifying draw. After finishing fourth in the Premiership last term, they are ...

Dundee United have agreed a deal to sign Moldova international Iurie Iovu. United have thrashed out a fee to sign the 22-year-old from Croatian side Istra 1961.

United would also typically need to comply with UEFA’s financial fair play rules, which carry a stricter limit on allowable losses — usually €60m (£50.5m, $68.3m) over three years, after ...

Aptose Biosciences has been thrown a financial lifeline by its own CEO while the leukemia-focused biotech scrambles around for cash to prevent the company from going bust. The Canadian biotech ...